Sunzen Group Berhad (KLSE:SUNZEN)

Market Cap	207.27M
Revenue (ttm)	95.12M
Net Income (ttm)	6.03M
Shares Out	767.66M
EPS (ttm)	0.01
PE Ratio	36.82
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,271,900
Average Volume	457,140
Open	0.2650
Previous Close	0.2700
Day's Range	0.2650 - 0.2750
52-Week Range	0.2600 - 0.3500
Beta	0.40
RSI	49.18
Earnings Date	Nov 21, 2025

About Sunzen Group Berhad

Sunzen Group Berhad engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through three segments: Animal Health, Human Health, and Loan Financing. The company provides veterinary machines, pharmaceutical, chemical products, animal health products and equipment, laboratory services, and beauty and cosmetic products. It also manufactures and sells traditional Chinese medicine, herbal health foods, beverages, and other p...

• Industry: Pharmaceutical Preparations
• Founded: 1998
• Country: Malaysia
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: SUNZEN

Financial Performance

In 2024, Sunzen Group Berhad's revenue was 95.12 million, a decrease of -3.07% compared to the previous year's 98.13 million. Earnings were 6.03 million, a decrease of -11.35%.